Navellier & Associates’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
PAI
GCM
Navellier & Associates's STAA Position: Q1 2022 in Review
Navellier & Associates sold out of STAAR Surgical (STAA) in Q1 2022, closing a stake of 5,490 shares — an estimated $501K sold.
Navellier & Associates first reported a position in STAA in Q1 2021 and held it in 4 quarters. The position peaked at $756K in Q2 2021. 270 funds tracked by Wall St. Rank hold STAA as of Q1 2022.
- Navellier & Associates reported no remaining STAAR Surgical position as of Q1 2022 after selling out during the quarter.
- Navellier & Associates sold 5,490 STAAR Surgical shares in Q1 2022, an estimated $501K.
- Navellier & Associates first reported a position in STAAR Surgical in Q1 2021 and held it in 4 quarters.
- Navellier & Associates's STAAR Surgical position peaked at $756K in Q2 2021.
- 270 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2022.
Based on Navellier & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.